Our second quarter edition features leading insights from key opinion leaders with findings specific to advanced therapies and orphan drugs.
Where Do Orphan Drugs Go From Here? Nice Insight
Accelerating The Development of Viral Vector Manufacturing Processes, Brammer Bio and Pall Corporation
Q&A: Building a Successful CDMO Brand, Brammer Bio
Keys to Successful Storage, Management and Transport of Biological Materials, Yourway
Integrated Outsourcing from RSMs to APIs, Albemarle Fine Chemistry Services
Bioprocess of the future: What’s In It for biomanufacturers?, MilliporeSigma
New Facility Presents Manufacturing Solutions for Recombinant Proteins, Grifols
Reducing Waste with Lean Delivery in Facility Design and Construction, CRB
Supporting Small and Emerging Pharma through Collaboration and Specialized Expertise, Grifols
The Renaissance of Microbial Fermentation, Northway Biotechpharma
Managing the Complexity of the Supply Chain for Cell and Gene Therapies, Marken
Exploring the Efficacy of Stem Cells in Reversing Age-Related Frailty, Longeveron
Supporting Commercialization with Specialized Technologies, UPM Pharmaceuticals
Social Networking and Information Exchange at China Pharma Week, CPhI & P-Mec China
Revisiting the Global Serialization Landscape, Servier
Come Home to Biovectra
Applying Enzymatic Synthesis for Chiral Molecules, SEQENS
An Expanding Orphan Drug Market, Developments in Orphan Drugs, David Alvaro, Ph.D., Cynthia Challener, Ph.D., Emilie Branch, Nice Insight
Managing the Risks Associated with Orphan Drug Development and Manufacturing, Developments in Orphan Drugs, David Alvaro, Ph.D., Cynthia Challener, Ph.D., Emilie Branch, Nice Insight
Navigating the Road to Successful Orphan Drug Commercialization and Launch, Developments in Orphan Drugs, David Alvaro, Ph.D., Cynthia Challener, Ph.D., Emilie Branch, Nice Insight
Supporting AAV and Lentiviral Vector Development and Commercialization, Aldevron
Oral Solid Dose Manufacturing for Customers Now and into the Future, Catalent
Taking Extra Care with Formulation, Frontida BioPharm, Inc.
Implementing Ready-to-Use Glass Vials for Flexible Aseptic Filling, SGD Pharma
Being at the Right Place at the Right Time, Taro Pharmaceuticals
Integrating ADC Manufacturing for the Future, Abzena
Quality and Experience Crucial for Sterility Assurance, Dalton Pharma Services
Polpharma Biologics: Building on Early Achievements
Speeding up ADC Development With the Right Partner Organization, Abbvie Contract Manufacturing
Plant-based protein expression for Rapid, Green Bioprocessing, iBio Inc.
Leveraging GMP-Grade Human Serum Albumin for Pharmaceutical Manufacturing, Grifols Bio Supplies
Advanced Therapies: Landscape, the Road Forward, and M&A, i.e. Advising
Running a CDMO Business is Hard – So Now Let’s Talk about Value Creation, Excellere Partners
Cancer’s New Foes—Novel Oncology Approaches in the Battle Against Cancer, Haig Barrett
The Value of Experience and Strategic Thinking, Chainbridge Ltd.
Following the Tobacco Road, Regulatory Spotlight, Nice Insight
Driving Innovation to Support Strategic Client Partnerships, Rentschler Biopharma
Designing a Customer-Centric CDMO, Patricio E. Massera, AGC Biologics
Manufacturing Technology, Roundtable
A Maturing Gene and Cell Therapy Market Drives Interest in Acquisitions, Sosna & Co.
Novel Therapies, Roundtable